喘息治療の世界市場:治療種類別、投与経路別、流通チャンネル別

• 英文タイトル:Asthma Treatment Market (Treatment Type: Long-term Asthma, Control Medications, Quick-relief (Rescue) Medications; Route of Administration: Inhaled, Oral, Intravenous, Subcutaneous; Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Asthma Treatment Market (Treatment Type: Long-term Asthma, Control Medications, Quick-relief (Rescue) Medications; Route of Administration: Inhaled, Oral, Intravenous, Subcutaneous; Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027「喘息治療の世界市場:治療種類別、投与経路別、流通チャンネル別」(市場規模、市場予測)調査レポートです。• レポートコード:TPM-NV195
• 出版社/出版日:Transparency Market Research / 2019年10月
• レポート形態:英文、PDF、213ページ
• 納品方法:Eメール
• 産業分類:製薬
• 販売価格(消費税別)
  Single User¥631,655 (USD5,795)▷ お問い合わせ
  Multi User¥958,655 (USD8,795)▷ お問い合わせ
  Global Site License¥1,285,655 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、喘息治療の世界市場について調べ、喘息治療の世界市場規模、市場動向、市場シェア、市場環境、市場予測、治療種類別(長期喘息、コントロール薬、クイックリリーフ(救助)薬)分析、投与経路別(吸入、経口、静脈内、皮下)分析、流通チャンネル別(小売薬局、病院薬局、オンライン薬局)分析、関連企業情報などをまとめました。
・喘息治療の市場概要
・喘息治療の市場動向
・喘息治療の世界市場規模・予測
・喘息治療市場:治療種類別(長期喘息、コントロール薬、クイックリリーフ(救助)薬)
・喘息治療市場:投与経路別(吸入、経口、静脈内、皮下)
・喘息治療市場:投与経路別(吸入、経口、静脈内、皮下)
・地域別分析(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争環境・関連企業分析

The global asthma treatment market will rise from a value of ~US$ 25.6 Bn in 2019 to ~US$ 30.5 Bn by 2027, and it is anticipated that an increase in the number of FDA-approved products in parallel to the increasing awareness among asthma patients regarding quality care will drive the steady odyssey of the market.

Analysts at Transparency Market Research (TMR) anticipate that, among the strategic approaches taken towards consolidation, partnerships and collaborations will remain integral to maximize profitability from new markets. Having witnessed product recalls, manufacturers in the asthma treatment market are dedicating ample efforts to develop high-quality products, which are likely to receive easy approvals from the FDA and similar regulatory bodies.

On the demand side, as awareness regarding quality care for the treatment of asthma increases among patients, the adoption of inhalers and oral drugs is likely to increase. However, in recent times, the cost-benefits of generic drugs have been appealing to patients, which could pose as a challenge for manufacturers in the asthma treatment market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Asthma Treatment Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Asthma Treatment Market Analysis and Forecast, 2017–2027

5. Market Outlook

5.1. Pipeline Analysis

5.2. Reimbursement Scenario

5.3. Disease Prevalence with Key Countries

6. Global Asthma Treatment Market Analysis and Forecasts, by Treatment Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

6.3.1. Long-term Asthma Control Medications

6.3.1.1. Inhaled Corticosteroids

6.3.1.2. Leukotriene Modifiers

6.3.1.3. Long-acting Beta Agonists

6.3.1.4. Combination Inhalers

6.3.1.5. Theophylline

6.3.1.6. Others (reslizumab, benralizumab, etc.)

6.3.2. Quick-relief (rescue) Medications

6.3.2.1. Short-acting Beta Agonists

6.3.2.2. Ipratropium (Atrovent)

6.3.2.3. Oral and Intravenous Corticosteroids

6.4. Global Asthma Treatment Market Attractiveness, by Treatment Type

7. Global Asthma Treatment Market Analysis and Forecasts, by Route of Administration

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Asthma Treatment Market Value (US$) Forecast, by Route of Administration, 2017–2027

7.3.1. Oral

7.3.2. Inhaled

7.3.3. Intravenous

7.3.4. Subcutaneous

7.4. Global Asthma Treatment Market Attractiveness, by Route of Administration

8. Global Asthma Treatment Market Analysis and Forecasts, by Distribution Channel

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

8.3.1. Hospital Pharmacies

8.3.2. Retail Pharmacies

8.3.3. Online Pharmacies

8.4. Global Asthma Treatment Market Attractiveness, by Distribution Channel

9. Global Asthma Treatment Market Analysis and Forecasts, by Region

9.1. Key Findings

9.2. Global Asthma Treatment Market Value (US$ Mn) Forecast, by Region

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Asthma Treatment Market Attractiveness, by Region

10. North America Asthma Treatment Market Analysis and Forecast

10.1. Introduction

10.2. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

10.2.1. Long-term Asthma Control Medications

10.2.1.1. Inhaled Corticosteroids

10.2.1.2. Leukotriene Modifiers

10.2.1.3. Long-acting Beta Agonists

10.2.1.4. Combination Inhalers

10.2.1.5. Theophylline

10.2.1.6. Others (reslizumab, benralizumab, etc.)

10.2.2. Quick-relief (rescue) Medications

10.2.2.1. Short-acting Beta Agonists

10.2.2.2. Ipratropium (Atrovent)

10.2.2.3. Oral and Intravenous Corticosteroids

10.3. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

10.3.1. Oral

10.3.2. Inhaled

10.3.3. Intravenous

10.3.4. Subcutaneous

10.4. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

10.4.1. Hospital Pharmacies

10.4.2. Retail Pharmacies

10.4.3. Online Pharmacies

10.5. North America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Asthma Treatment Market Attractiveness Analysis

10.6.1. By Treatment Type

10.6.2. By Route of Administration

10.6.3. By Distribution Channel

10.6.4. By Country/Sub-region

11. Europe Asthma Treatment Market Analysis and Forecast

11.1. Introduction

11.2. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

11.2.1. Long-term Asthma Control Medications

11.2.1.1. Inhaled Corticosteroids

11.2.1.2. Leukotriene Modifiers

11.2.1.3. Long-acting Beta Agonists

11.2.1.4. Combination Inhalers

11.2.1.5. Theophylline

11.2.1.6. Others (reslizumab, benralizumab etc.)

11.2.2. Quick-relief (rescue) Medications

11.2.2.1. Short-acting Beta Agonists

11.2.2.2. Ipratropium (Atrovent)

11.2.2.3. Oral and Intravenous Corticosteroids

11.3. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

11.3.1. Oral

11.3.2. Inhaled

11.3.3. Intravenous

11.3.4. Subcutaneous

11.4. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

11.4.1. Hospital Pharmacies

11.4.2. Retail Pharmacies

11.4.3. Online Pharmacies

11.5. Europe Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Asthma Treatment Market Attractiveness Analysis

11.6.1. By Treatment Type

11.6.2. By Route of Administration

11.6.3. By Distribution Channel

11.6.4. By Country/Sub-region

12. Asia Pacific Asthma Treatment Market Analysis and Forecast

12.1. Introduction

12.2. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

12.2.1. Long-term Asthma Control Medications

12.2.1.1. Inhaled Corticosteroids

12.2.1.2. Leukotriene Modifiers

12.2.1.3. Long-acting Beta Agonists

12.2.1.4. Combination Inhalers

12.2.1.5. Theophylline

12.2.1.6. Others (reslizumab, benralizumab etc.)

12.2.2. Quick-relief (rescue) Medications

12.2.2.1. Short-acting Beta Agonists

12.2.2.2. Ipratropium (Atrovent)

12.2.2.3. Oral and Intravenous Corticosteroids

12.3. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

12.3.1. Oral

12.3.2. Inhaled

12.3.3. Intravenous

12.3.4. Subcutaneous

12.4. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Online Pharmacies

12.5. Asia Pacific Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

12.5.1. China

12.5.2. Japan

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Asthma Treatment Market Attractiveness Analysis

12.6.1. By Treatment Type

12.6.2. By Route of Administration

12.6.3. By Distribution Channel

12.6.4. By Country/Sub-region

13. Latin America Asthma Treatment Market Analysis and Forecast

13.1. Introduction

13.2. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

13.2.1. Long-term Asthma Control Medications

13.2.1.1. Inhaled Corticosteroids

13.2.1.2. Leukotriene Modifiers

13.2.1.3. Long-acting Beta Agonists

13.2.1.4. Combination Inhalers

13.2.1.5. Theophylline

13.2.1.6. Others (reslizumab, benralizumab etc.)

13.2.2. Quick-relief (rescue) Medications

13.2.2.1. Short-acting Beta Agonists

13.2.2.2. Ipratropium (Atrovent)

13.2.2.3. Oral and Intravenous Corticosteroids

13.3. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

13.3.1. Oral

13.3.2. Inhaled

13.3.3. Intravenous

13.3.4. Subcutaneous

13.4. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

13.4.1. Hospital Pharmacies

13.4.2. Retail Pharmacies

13.4.3. Online Pharmacies

13.5. Latin America Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Asthma Treatment Market Attractiveness Analysis

13.6.1. By Treatment Type

13.6.2. By Route of Administration

13.6.3. By Distribution Channel

13.6.4. By Country/Sub-region

14. Middle East & Africa Asthma Treatment Market Analysis and Forecast

14.1. Introduction

14.2. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017–2027

14.2.1. Long-term Asthma Control Medications

14.2.1.1. Inhaled Corticosteroids

14.2.1.2. Leukotriene Modifiers

14.2.1.3. Long-acting Beta Agonists

14.2.1.4. Combination Inhalers

14.2.1.5. Theophylline

14.2.1.6. Others (reslizumab, benralizumab etc.)

14.2.2. Quick-relief (rescue) Medications

14.2.2.1. Short-acting Beta Agonists

14.2.2.2. Ipratropium (Atrovent)

14.2.2.3. Oral and Intravenous Corticosteroids

14.3. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027

14.3.1. Oral

14.3.2. Inhaled

14.3.3. Intravenous

14.3.4. Subcutaneous

14.4. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Online Pharmacies

14.5. Middle East & Africa Asthma Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region , 2017–2027

14.5.1. GCC

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Asthma Treatment Market Attractiveness Analysis

14.6.1. By Treatment Type

14.6.2. By Route of Administration

14.6.3. By Distribution Channel

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Share Analysis, by Company (2018)

15.2. Company Profiles

15.2.1. AstraZeneca

15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.1.2. Company Financials

15.2.1.3. Growth Strategies

15.2.1.4. SWOT Analysis

15.2.2. Boehringer Ingelheim International GmbH

15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.2.2. Company Financials

15.2.2.3. Growth Strategies

15.2.2.4. SWOT Analysis

15.2.3. GlaxoSmithKline plc

15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.3.2. Company Financials

15.2.3.3. Growth Strategies

15.2.3.4. SWOT Analysis

15.2.4. Novartis AG

15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.4.2. Company Financials

15.2.4.3. Growth Strategies

15.2.4.4. SWOT Analysis

15.2.5. Teva Pharmaceutical Industries Ltd

15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.5.2. Company Financials

15.2.5.3. Growth Strategies

15.2.5.4. SWOT Analysis

15.2.6. Sumitomo Dainippon Pharma Co., Ltd

15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.6.2. Company Financials

15.2.6.3. Growth Strategies

15.2.6.4. SWOT Analysis

15.2.7. Merck & Co., Inc.

15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.7.2. Company Financials

15.2.7.3. Growth Strategies

15.2.7.4. SWOT Analysis

15.2.8. F. Hoffmann-La Roche Ltd.

15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.8.2. Company Financials

15.2.8.3. Growth Strategies

15.2.8.4. SWOT Analysis

15.2.9. Sanofi

15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.9.2. Company Financials

15.2.9.3. Growth Strategies

15.2.9.4. SWOT Analysis

15.2.10. Mylan N.V.

15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

15.2.10.2. Company Financials

15.2.10.3. Growth Strategies

15.2.10.4. SWOT Analysis




• 英文レポート名:Asthma Treatment Market (Treatment Type: Long-term Asthma, Control Medications, Quick-relief (Rescue) Medications; Route of Administration: Inhaled, Oral, Intravenous, Subcutaneous; Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027
• 日本語訳:喘息治療の世界市場:治療種類別、投与経路別、流通チャンネル別
• レポートコード:TPM-NV195お問い合わせ(見積依頼・ご注文・質問)